Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 500 Plaza Drive (State of Incorporation) (I.R.S. Employer Identification Number) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly perio ...

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Shawn Bevec - Vice President, Investor Relations Jim Davis - Chairman and Chief Executive Officer and President Sam Samad - Chief Financial Officer. Conference Call Participants Ann Hynes - Mizuho Securities Patrick Donnelly - Citigroup Brian Tanquilut - Jefferies Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Jack Meehan - Nephron Research Erin Wright - Morgan Stanley Kieran Rya ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 500 Plaza Drive (State of Incorporation) (I.R.S. Employ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number 001-12215 Quest Diagnostics Incorporated 500 Plaza Drive Secaucus, NJ 07094 (973) 520-2700 Delaware 16-1387862 ...

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2022 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice President, Chief Financial Officer Shawn Bevec - Vice President, Investor Relations Conference Call Participants Ann Hynes - Mizuho Securities Patrick Donnelly - Citi Jack Meehan - Nephron Research AJ Rice - Credit Suisse Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Kevin Caliendo - UBS Andrew Brac ...

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2022 Earnings Conference Call October 20, 2022 8:30 AM ET Company Participants Shawn Bevec - VP of IR Steve Rusckowski - Chairman, President & Chief Executive Officer Jim Davis - CEO Sam Samad - CFO Conference Call Participants Ann Hynes - Mizuho Securities Kevin Caliendo - UBS Jack Meehan - Nephron Research Erin Wright - Morgan Stanley Brian Tanquilut - Jefferies A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Patrick Donnelly - Citi Operator Welcome t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 (State of Incorporation) (I.R.S. Employer Identific ...

Quest Diagnostics Incorporated (NYSE:DGX) Q2 2022 Earnings Conference Call July 21, 2022 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Steve Rusckowski - Chairman, President & Chief Executive Officer Jim Davis - Chief Executive Officer-Elect Mark Guinan - Chief Financial Officer Sam Samad - Executive Vice President & Incoming-Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies A.J. Rice - Credit Suisse Jack Meehan - Nephron Research Patrick D ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 (State of Incorporation) (I.R.S. Employer Identification ...

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2022 Earnings Conference Call April 21, 2022 8:30 AM ET Company Participants Shawn Bevec - Vice President, Investor Relations Steve Rusckowski - Chairman and Chief Executive Officer and President Jim Davis - Chief Executive Officer-Elect Mark Guinan - Chief Financial Officer Conference Call Participants Ricky Goldwasser - Morgan Stanley Patrick Donnelly - Citi A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Kevin Caliendo - UBS Jack Meehan - Nephron Res ...